Adagio Medical Statistics
Share Statistics
Adagio Medical has 15.38M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 15.38M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 89 |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.3 and the forward
PE ratio is null.
Adagio Medical's PEG ratio is
0.01.
| PE Ratio | -0.3 |
| Forward PE | n/a |
| PS Ratio | 59.32 |
| Forward PS | n/a |
| PB Ratio | 0.8 |
| P/FCF Ratio | -0.98 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Adagio Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27,
with a Debt / Equity ratio of 0.82.
| Current Ratio | 3.27 |
| Quick Ratio | 2.93 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | -0.26 |
| Debt / FCF | -0.99 |
| Interest Coverage | 56.7 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $3,362.5 |
| Profits Per Employee | $-672,037.5 |
| Employee Count | 80 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0.19, so Adagio Medical's
price volatility has been higher than the market average.
| Beta | 0.19 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 56.1 |
| Average Volume (20 Days) | 2,063,385 |
Income Statement
In the last 12 months, Adagio Medical had revenue of 269K
and earned -53.76M
in profits. Earnings per share was -3.54.
| Revenue | 269K |
| Gross Profit | -1.67M |
| Operating Income | -62.48M |
| Net Income | -53.76M |
| EBITDA | -62.48M |
| EBIT | -54.87M |
| Earnings Per Share (EPS) | -3.54 |
Full Income StatementBalance Sheet
The company has 20.59M in cash and 16.27M in
debt, giving a net cash position of 4.32M.
| Cash & Cash Equivalents | 20.59M |
| Total Debt | 16.27M |
| Net Cash | 4.32M |
| Retained Earnings | -70.59M |
| Total Assets | 107.2M |
| Working Capital | 27.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -15.99M
and capital expenditures -368K, giving a free cash flow of -16.36M.
| Operating Cash Flow | -15.99M |
| Capital Expenditures | -368K |
| Free Cash Flow | -16.36M |
| FCF Per Share | -1.08 |
Full Cash Flow StatementMargins
Gross margin is -620.07%, with operating and profit margins of -23226.77% and -19986.25%.
| Gross Margin | -620.07% |
| Operating Margin | -23226.77% |
| Pretax Margin | -19986.25% |
| Profit Margin | -19986.25% |
| EBITDA Margin | -23226.77% |
| EBIT Margin | -23226.77% |
| FCF Margin | -6081.04% |
